Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01754168 · ClinicalTrials.gov registry record
Amyloid Beta and Cognition in Parkinson Disease
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 44
- Enrollment target
NCT01754168 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 44 participants.
The verdict
NCT01754168 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
The investigators propose to study persons with Parkinson Disease (PD) with detailed clinical, cognitive and imaging at the time of study entry and repeat these assessments 2 years later. The study looks at how changes in activity of the neurotransmitter acetylcholine relates to changes in cognitive function and to see if there is presence or build up of amyloid protein.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2013-02 |
| Est. Completion | 2018-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01754168
The ClinicalTrials.gov registry entry for NCT01754168 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01754168 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01754168 about?
NCT01754168 is a clinical study titled "Amyloid Beta and Cognition in Parkinson Disease". The investigators propose to study persons with Parkinson Disease (PD) with detailed clinical, cognitive and imaging at the time of study entry and repeat these assessments 2 years later. The study looks at how changes in activity of the neurotransmitter acetylcholine relates to changes in cognitive...
What is the current status of trial NCT01754168?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2013-02. Estimated completion is 2018-02.
Who is sponsoring clinical trial NCT01754168?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.